Zai Lab Limited Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Zai Lab Limited's inventory turnover ratio sequentially decreased to 3.39 in the second quarter 2026, otherwise the ratio remained above the average, as ZLAB's markets remain strong.Zai Lab Limited's average inventory processing period in the Jun 30 2026 quarter, has increased to 108 days, from 84 days, in the Mar 31 2026 quarter.

Within Healthcare sector 137 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1260, from total ranking in the first quarter 2026 at 1275.

ZLAB Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Zai Lab Limited Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ZLAB Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	148.78 %	59.34 %	90.53 %	80.94 %	56.36 %
Y / Y Cost of Sales Growth	12 %	-0.36 %	49.11 %	27.88 %	22.35 %
Inventory Turnover Ratio (TTM)	3.39	4.32	4.87	5.05	5.49
ZLAB's Total Ranking	# 1260	# 1275	# 862	# 772	# 713
Average inventory processing period	108	84	75	72	67
Seq. Inventory Growth	70.62 %	16.19 %	12.81 %	11.24 %	9.28 %
Seq. Cost of Sales Growth	25.7 %	-38.5 %	33.22 %	8.75 %	11.84 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 33
Healthcare Sector	# 138
Overall Market	# 1260

Inventory Turnover Ratio Statistics
High	Average	Low
11.41	2.92	0.01
(Dec 31 2018)		0

ZLAB Company Profile >> Back to ZLAB Efficiency Comparisons >> Compare ZLAB Inventory Turnover Ratio to its Competitors

Financial Statements
Zai Lab Limited's Inventories	$ 91 Millions	Visit ZLAB's Balance sheet
Zai Lab Limited's Cost of Revenues TTM	$ 196 Millions	Visit ZLAB's Income Statement
What are ZLAB's Sales?		Visit ZLAB's Sales by Segment

Other Inventory Turnover Ratios
Zai Lab Limited's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ZLAB's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ZLAB's Competitors
Inventory Turnover Ratio for ZLAB's Suppliers
Inventory Turnover Ratio for ZLAB's Customers

You may also want to know
ZLAB's Sales Growth Rates	ZLAB's Pe Price to earnings ratio	ZLAB's Receivables Turnover Ratio	ZLAB's Stock Quote
ZLAB's Net Income Growth Rates	ZLAB's Ps Price to Sales ratio	ZLAB's Sales per Employee	ZLAB's Asset Turnover Ratio
ZLAB's Net Margin	ZLAB's Pb Price to Book ratio	ZLAB's Financial Strength Ratios	ZLAB's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Sharps Technology Inc	5.68	$ 2.869 Millions	$ 1 Millions
Transmedics Group Inc	5.59	$ 276.120 Millions	$ 49 Millions
Opko Health Inc	5.42	$ 348.206 Millions	$ 64 Millions
Charles River Laboratories International inc	5.39	$ 1,761.363 Millions	$ 327 Millions
Tactile Systems Technology Inc	5.12	$ 81.349 Millions	$ 16 Millions
Integer Holdings Corporation	5.03	$ 1,369.168 Millions	$ 272 Millions
Harrow Inc	4.93	$ 73.636 Millions	$ 15 Millions
Ufp Technologies Inc	4.93	$ 452.046 Millions	$ 92 Millions
Veracyte Inc	4.84	$ 102.741 Millions	$ 21 Millions
West Pharmaceutical Services Inc	4.72	$ 2,103.100 Millions	$ 445 Millions
Henry Schein Inc	4.68	$ 9,342.000 Millions	$ 1,997 Millions
Guardant Health Inc	4.53	$ 413.947 Millions	$ 91 Millions
Idexx Laboratories Inc	4.44	$ 1,714.440 Millions	$ 386 Millions
Adc Therapeutics Sa	4.17	$ 5.806 Millions	$ 1 Millions
Scilex Holding Company	4.08	$ 14.867 Millions	$ 4 Millions
Medinotec Inc	4.08	$ 4.736 Millions	$ 1 Millions
3m Company	4.07	$ 15,258.000 Millions	$ 3,754 Millions
Electromed Inc	4.02	$ 14.133 Millions	$ 4 Millions
Novocure Limited	4.02	$ 166.921 Millions	$ 41 Millions
Elite Pharmaceuticals Inc	3.95	$ 78.824 Millions	$ 20 Millions
Lftd Partners Inc	3.89	$ 29.233 Millions	$ 8 Millions
Pmgc Holdings Inc	3.87	$ 1.364 Millions	$ 0 Millions
Sonoma Pharmaceuticals Inc	3.83	$ 13.392 Millions	$ 3 Millions
Intelligent Bio Solutions Inc	3.80	$ 2.165 Millions	$ 1 Millions
Iridex Corp	3.80	$ 32.517 Millions	$ 9 Millions
Teva Pharmaceutical Industries Limited	3.66	$ 8,232.000 Millions	$ 2,250 Millions
Neuraxis Inc	3.55	$ 0.783 Millions	$ 0 Millions
Beyond Air Inc	3.51	$ 6.447 Millions	$ 2 Millions
Nexgel Inc	3.49	$ 7.577 Millions	$ 2 Millions
Lifeward ltd	3.47	$ 13.976 Millions	$ 4 Millions

Date modified: 2026-09-06T17:20:12+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.